Tumor cells recruit macrophage bodyguards to outlast chemotherapy
Cancer Cell · 2026
DOI: 10.1016/j.ccell.2026.07.015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cell, 2026. Verfasst von Yuzhao Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou…. Hauptthemen laut MEDLINE: Macrophages, Drug Resistance, Neoplasm, Urinary Bladder Neoplasms, Antineoplastic Agents. Die Arbeit nennt 10 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
In Cell Press Blue, Carvalho et al. identify spatially organized tumor-macrophage niches, EMT-like CD44high cancer cells paired with SPP1/PARP14high macrophages, that drive chemoresistance in bladder cancer. PARP14 inhibition can flip this protective niche into an inflammatory, cisplatin-sensitizing state.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China; Department of Urology, Sun Yat-sen University Cancer C…
Zitieren
APA
Wang, Y., Chen, Z., Liu, Z., & Ma, Z. (2026). Tumor cells recruit macrophage bodyguards to outlast chemotherapy. Cancer Cell. https://doi.org/10.1016/j.ccell.2026.07.015
Vancouver
Wang Y, Chen Z, Liu Z, Ma Z. Tumor cells recruit macrophage bodyguards to outlast chemotherapy. Cancer Cell. 2026. doi:10.1016/j.ccell.2026.07.015
BibTeX
@article{Wang2026,
author = {Wang, Yuzhao and Chen, Zibin and Liu, Zhuowei and Ma, Zikun},
title = {Tumor cells recruit macrophage bodyguards to outlast chemotherapy},
journal = {Cancer Cell},
year = {2026},
doi = {10.1016/j.ccell.2026.07.015}
}
EUVIMED